Search results
Pfizer's first-quarter results top estimates, while drugmaker boosts full-year profit outlook
Morningstar· 13 hours agoPfizer Inc. on Wednesday reported first-quarter profit and sales that beat analyst expectations and raised its full-year earnings guidance as cancer and heart-disease drugs ...
Pfizer Stock Gets Boost From Better-Than-Expected Earnings
Investopedia· 8 hours agoThe company posted adjusted net income, which doesn't account for items such as impact of...
Pfizer stock gains 7% after earnings beat, company calls dividend 'secure'
Yahoo Finance via AOL· 5 hours ago[and] we do not believe that COVID upside alone ... is enough to drive shares higher in the...
U.S. to start offering COVID-19 vaccine booster doses in September
AOL· 3 days agoThe White House is prepared to offer a third booster shot starting on that date to all Americans who...
Pfizer (PFE) Q1 Earnings & Sales Top, EPS Guidance Raised
Zacks via Yahoo Finance· 9 hours agoThe revenue decline, as expected, was due to a steep drop in revenues from its COVID-19 products,...
Pfizer’s first-quarter results top estimates, while drugmaker boosts full-year profit outlook
Market Watch· 14 hours agoAn expected drop in COVID-19-related product sales, including antiviral Paxlovid and vaccine...
Pfizer lifts profit view on cost cuts, demand for COVID products
Reuters· 7 hours agoSales of Padcev, a treatment for advanced bladder cancer Pfizer gained through its $43 billion deal...
CDC Found Evidence COVID-19 Vaccines Caused Deaths
WSAU Wausau· 7 hours agoIn an exclusive report by the Epoch Times, U.S. Centers for Disease Control and Prevention (CDC) officials fou...
Pfizer (PFE) Q1 2024 Earnings Call Transcript
Motley Fool via Yahoo Finance· 3 hours agoWe believe Abrysvo has the potential to become the first and only RSV vaccine for adults 18 years and older. Hematology is another priority area. With...
Pfizer Inc (PFE) Q1 2024 Earnings: Adjusted EPS Surpasses Expectations Amidst Revenue Decline
GuruFocus.com via Yahoo Finance· 12 hours agoStrategic and Operational Highlights Despite the challenges posed by declining COVID-19 product...
